Dinginleştirici, Uyutucu ve Kaygı Gidericiler (Diazepam, Klorazepat vb.) Kullanım Bozukluğu ve Ebelik Yaklaşımı
References
Polat AD, Oğuz F, Salihoğlu S, Pak Güre MD. Sürdürülebilir kalkınma amaçları kapsamında madde bağımlılığıyla mücadelede sosyal hizmetin rolü. JSWR. 2022; 2(29): 191-204.
Parsaik AK, Mascarenhas SS, Khosh-Chashm D, et al. Mortality associated with anxiolytic and hypnotic drugs - A systematic review and meta-analysis. Australian & New Zealand Journal of Psychiatry. 2016; 50(6): 520–533. doi:10.1177/0004867415616695.
Yonkers KA, Gilstad-Hayden K, Forray A, Lipkind HS. Association of panic disorder, generalized anxiety disorder, and benzodiazepine treatment during pregnancy with risk of adverse birth outcomes. JAMA Psychiatry. 2017; 74(11): 1145-1152. doi:10.1001/jamapsychiatry.2017.2733
South Western Sydney LHD Mental Health Services, Transcultural Mental Health Center. Benzodiazepins 2013. Erişim adresi: https://www.dhi.health.nsw.gov.au/ArticleDocuments/304/Benzodiazepines_Turkish2013.pdf.aspx Erişim tarihi: 13.05.2024.
Iqbal MM, Sobhan T, Ryals T. Effects of commonly used benzodiazepines on the fetus, the neonate, and the nursing infant. Psychiatric Services. 2002; 53(1): 39-49. doi:10.1176/appi.ps.53.1.39.
Gök Ş. Benzodiazepinler. Türkiye Klinikleri. 2006; 2(1): 1-10.
Shyken J, Babbar S, Babbar S, Forinash A. Benzodiazepines in pregnancy. Clin. Obstet. Gynaecol.. 2019; 62(1): 156-167. doi:10.1097/GRF.0000000000000417.
Bais B, Molenaara N, Bijmac HH, et al. Prevalence of benzodiazepines and benzodiazepine-related drugs exposure before, during and after pregnancy: A systematic review and meta-analysis. J. Affective Disord. 2020; 269: 18-27. doi:10.1016/j.jad.2020.03.014.
Dolovich LR, Addis A, Vaillancourt JMR, et al. Benzodiazepine use in pregnancy and majör malformations or oral cleft: meta-analysis of cohort and case-control studies. Therapie. 2000; 55(5): 587-595.
Bellantuono C, Tofani S, Di Sciascio G, Santone G. Benzodiazepine exposure in pregnancy and risk of major malformations: A critical overview. Gen. Hosp. Psychiatry. 2013; 35(1): 3-8. doi:10.1016/j.genhosppsych.2012.09.003.
Bukowski, H. B., & Combellick, J. L. Midwifery care of pregnant individuals experiencing opioid use disorder: changing regulations, complexities, and call to action. JMWH. 2022; 67(6): 770-776.
Weber, A., Miskle, B., Lynch, A., Arndt, S., & Acion, L. Substance use in pregnancy: identifying stigma and improving care. Subst. Abuse Rehabil. 2021; 12: 105-121.
Lukačišinová A, Reissigová J, Ortner-Hadžiabdić M, et al. Prevalence, country-specific prescribing patterns and determinants of benzodiazepine use in community-residing older adults in 7 European countries. BMC Geriatrics. 2024; 24(1): 1-13. doi:10.1186/s12877-024-04742-7.
Grigoriadis S, Graves L, Peer M, et al. Pregnancy and delivery outcomes following benzodiazepine exposure: A systematic review and meta-analysis. Can. J. Psychiatry. 2020; 65(12): 821-834. doi:10.1177/0706743720904860.
McLafferty LP, Becker M, Dresner N, et al. Guidelines for the management of pregnant women with substance use disorders. Psychosomatics. 2016; 57(2): 115-130. doi: 10.1016/j.psym.2015.12.001.
Askaa B, Jimenez-Solem E, Enghusen Poulsen H, Traerup Andersen J. Maternal characteristics of women exposed to hypnotic benzodiazepine receptor agonist during pregnancy. Obstetrics and Gynecology International. 2014; 1: 1-5. doi:10.1155/2014/945621.
Hanley GE, Mintzes B. Patterns of psychotropic medicine use in pregnancy in the United States from 2006 to 2011 among women with private insurance. BMC Pregnancy Childb. 2014; 14 (242): 1-12. doi:10.1186/1471-2393-14-242.
Sheehy O, Zhao J, Bérard A. Association between ıncident exposure to benzodiazepines in early pregnancy and risk of spontaneous abortion. JAMA Psychiatry. 2019; 76(9): 948-957. doi:10.1001/jamapsychiatry.2019.0963.
Çeliker A, Bolat D. Bağımlılık yapan maddelerin gebelik döneminde kullanımının değerlendirilmesi. FABAD Journal of Pharmaceutical Sciences. 2021; 46(2): 225-250.
Barends C, Absalom A. Anxiolytics, sedatives and hypnotics. Anaesthesia & Intensive Care Medicine. 2016; 17(8): 411-417. doi:10.1016/j.mpaic.2016.05.002.
Karcıoğlu O. Benzodiazepin Zehirlenmeleri. In: Satar S (ed.) Acilde Klinik Toksikoloji. 1. Baskı. Nobel Tıp Kitabevleri, 2009. ss. 1-4.
American Psychiatric Association, Substance-Related and Addictive Disorders. Diagnostic and statistical manual of mental disorders fifth edition text revision DSM-5-TR 2022 Erişim adresi: https://www.mredscircleoftrust.com/storage/app/media/DSM%205%20TR.pdf Erişim tarihi: 13.05.2024.
Huitfeldt A, Sundbakk LM, Skurtveit S, Handal M, Nordeng H. Associations of maternal use of benzodiazepines or benzodiazepine-like hypnotics during pregnancy with immediate pregnancy outcomes in Norway. Pharmacy and Clinical Pharmacology. JAMA Network Open. 2020; 3(6): e205860. doi:10.1001/jamanetworkopen.2020.5860.
Çetin M. Gebelikte psikotrop ilaç kullanımı: Bir güncelleme. Klinik Psikofarmakoloji Bülteni. 2011; 21(2): 161-173. doi:10.5455/bcp.20110706032759.
Kadıoğlu Duman M, Kalyoncu Nİ. Psikotrop İlaçlar (Antidepresitler, Lityum, Antipsikotikler, Sedatif-Hipnotikler). In: Kalyoncu Nİ, Kadıoğlu Duman M (eds.) Gebelik ve Emzirme Döneminde Klinik Farmakoloji. 1. Baskı. Ankara: Türkiye Klinikleri, 2018. ss.144-154.
Norstedt Wikner B, Stiller C, Bergman U, C, Kalle´n B. Use of benzodiazepines and benzodiazepine receptor agonists during pregnancy: neonatal outcome and congenital malformations. Pharmacoepidemiol. Drug Saf. 2007; 16 (11): 1203–1210. doi:10.1002/pds.1457.
Gopalan P, Moses-Kolko E, Valpey R, Shenai N, Smith E. Benzodiazepine withdrawal in pregnant women with opioid use disorders: an observational study of current clinical practices at a tertiary obstetrical hospital. Gen. Hosp. Psychiatry. 2019; 57: 29-33. doi: 10.1016/j.genhosppsych.2018.12.005.
Çıtak S. Anksiyete bozukluklarında tedavi yaklaşımları: psikoterapi ve farmakoterapi. Türkiye Klinikleri. 2018; 9(3): 141-149.
Copoglu ÜS, Kokacya MH, Demircan C. Gebelik ve laktasyon döneminde ruhsal bozukluklar ve tedavisi. Mustafa Kemal Üniversitesi Tıp Dergisi; 2015; 6(24): 43-53. doi:10.17944/mkutfd.81777.
Akkurt Yalçıntürk A. Gebelikte madde kötüye kullanımı ve hemşirelerin sorumlulukları. Marmara Sağlık Hizmetleri Dergisi. 2017; 1(2): 45-50. doi:10.26567/marsag.2017237426.
Parsaik AK, Mascarenhas SS, Khosh-Chashm D, et al. Mortality associated with anxiolytic and hypnotic drugs - A systematic review and meta-analysis. Australian & New Zealand Journal of Psychiatry. 2016; 50(6): 520–533. doi:10.1177/0004867415616695.
Yonkers KA, Gilstad-Hayden K, Forray A, Lipkind HS. Association of panic disorder, generalized anxiety disorder, and benzodiazepine treatment during pregnancy with risk of adverse birth outcomes. JAMA Psychiatry. 2017; 74(11): 1145-1152. doi:10.1001/jamapsychiatry.2017.2733
South Western Sydney LHD Mental Health Services, Transcultural Mental Health Center. Benzodiazepins 2013. Erişim adresi: https://www.dhi.health.nsw.gov.au/ArticleDocuments/304/Benzodiazepines_Turkish2013.pdf.aspx Erişim tarihi: 13.05.2024.
Iqbal MM, Sobhan T, Ryals T. Effects of commonly used benzodiazepines on the fetus, the neonate, and the nursing infant. Psychiatric Services. 2002; 53(1): 39-49. doi:10.1176/appi.ps.53.1.39.
Gök Ş. Benzodiazepinler. Türkiye Klinikleri. 2006; 2(1): 1-10.
Shyken J, Babbar S, Babbar S, Forinash A. Benzodiazepines in pregnancy. Clin. Obstet. Gynaecol.. 2019; 62(1): 156-167. doi:10.1097/GRF.0000000000000417.
Bais B, Molenaara N, Bijmac HH, et al. Prevalence of benzodiazepines and benzodiazepine-related drugs exposure before, during and after pregnancy: A systematic review and meta-analysis. J. Affective Disord. 2020; 269: 18-27. doi:10.1016/j.jad.2020.03.014.
Dolovich LR, Addis A, Vaillancourt JMR, et al. Benzodiazepine use in pregnancy and majör malformations or oral cleft: meta-analysis of cohort and case-control studies. Therapie. 2000; 55(5): 587-595.
Bellantuono C, Tofani S, Di Sciascio G, Santone G. Benzodiazepine exposure in pregnancy and risk of major malformations: A critical overview. Gen. Hosp. Psychiatry. 2013; 35(1): 3-8. doi:10.1016/j.genhosppsych.2012.09.003.
Bukowski, H. B., & Combellick, J. L. Midwifery care of pregnant individuals experiencing opioid use disorder: changing regulations, complexities, and call to action. JMWH. 2022; 67(6): 770-776.
Weber, A., Miskle, B., Lynch, A., Arndt, S., & Acion, L. Substance use in pregnancy: identifying stigma and improving care. Subst. Abuse Rehabil. 2021; 12: 105-121.
Lukačišinová A, Reissigová J, Ortner-Hadžiabdić M, et al. Prevalence, country-specific prescribing patterns and determinants of benzodiazepine use in community-residing older adults in 7 European countries. BMC Geriatrics. 2024; 24(1): 1-13. doi:10.1186/s12877-024-04742-7.
Grigoriadis S, Graves L, Peer M, et al. Pregnancy and delivery outcomes following benzodiazepine exposure: A systematic review and meta-analysis. Can. J. Psychiatry. 2020; 65(12): 821-834. doi:10.1177/0706743720904860.
McLafferty LP, Becker M, Dresner N, et al. Guidelines for the management of pregnant women with substance use disorders. Psychosomatics. 2016; 57(2): 115-130. doi: 10.1016/j.psym.2015.12.001.
Askaa B, Jimenez-Solem E, Enghusen Poulsen H, Traerup Andersen J. Maternal characteristics of women exposed to hypnotic benzodiazepine receptor agonist during pregnancy. Obstetrics and Gynecology International. 2014; 1: 1-5. doi:10.1155/2014/945621.
Hanley GE, Mintzes B. Patterns of psychotropic medicine use in pregnancy in the United States from 2006 to 2011 among women with private insurance. BMC Pregnancy Childb. 2014; 14 (242): 1-12. doi:10.1186/1471-2393-14-242.
Sheehy O, Zhao J, Bérard A. Association between ıncident exposure to benzodiazepines in early pregnancy and risk of spontaneous abortion. JAMA Psychiatry. 2019; 76(9): 948-957. doi:10.1001/jamapsychiatry.2019.0963.
Çeliker A, Bolat D. Bağımlılık yapan maddelerin gebelik döneminde kullanımının değerlendirilmesi. FABAD Journal of Pharmaceutical Sciences. 2021; 46(2): 225-250.
Barends C, Absalom A. Anxiolytics, sedatives and hypnotics. Anaesthesia & Intensive Care Medicine. 2016; 17(8): 411-417. doi:10.1016/j.mpaic.2016.05.002.
Karcıoğlu O. Benzodiazepin Zehirlenmeleri. In: Satar S (ed.) Acilde Klinik Toksikoloji. 1. Baskı. Nobel Tıp Kitabevleri, 2009. ss. 1-4.
American Psychiatric Association, Substance-Related and Addictive Disorders. Diagnostic and statistical manual of mental disorders fifth edition text revision DSM-5-TR 2022 Erişim adresi: https://www.mredscircleoftrust.com/storage/app/media/DSM%205%20TR.pdf Erişim tarihi: 13.05.2024.
Huitfeldt A, Sundbakk LM, Skurtveit S, Handal M, Nordeng H. Associations of maternal use of benzodiazepines or benzodiazepine-like hypnotics during pregnancy with immediate pregnancy outcomes in Norway. Pharmacy and Clinical Pharmacology. JAMA Network Open. 2020; 3(6): e205860. doi:10.1001/jamanetworkopen.2020.5860.
Çetin M. Gebelikte psikotrop ilaç kullanımı: Bir güncelleme. Klinik Psikofarmakoloji Bülteni. 2011; 21(2): 161-173. doi:10.5455/bcp.20110706032759.
Kadıoğlu Duman M, Kalyoncu Nİ. Psikotrop İlaçlar (Antidepresitler, Lityum, Antipsikotikler, Sedatif-Hipnotikler). In: Kalyoncu Nİ, Kadıoğlu Duman M (eds.) Gebelik ve Emzirme Döneminde Klinik Farmakoloji. 1. Baskı. Ankara: Türkiye Klinikleri, 2018. ss.144-154.
Norstedt Wikner B, Stiller C, Bergman U, C, Kalle´n B. Use of benzodiazepines and benzodiazepine receptor agonists during pregnancy: neonatal outcome and congenital malformations. Pharmacoepidemiol. Drug Saf. 2007; 16 (11): 1203–1210. doi:10.1002/pds.1457.
Gopalan P, Moses-Kolko E, Valpey R, Shenai N, Smith E. Benzodiazepine withdrawal in pregnant women with opioid use disorders: an observational study of current clinical practices at a tertiary obstetrical hospital. Gen. Hosp. Psychiatry. 2019; 57: 29-33. doi: 10.1016/j.genhosppsych.2018.12.005.
Çıtak S. Anksiyete bozukluklarında tedavi yaklaşımları: psikoterapi ve farmakoterapi. Türkiye Klinikleri. 2018; 9(3): 141-149.
Copoglu ÜS, Kokacya MH, Demircan C. Gebelik ve laktasyon döneminde ruhsal bozukluklar ve tedavisi. Mustafa Kemal Üniversitesi Tıp Dergisi; 2015; 6(24): 43-53. doi:10.17944/mkutfd.81777.
Akkurt Yalçıntürk A. Gebelikte madde kötüye kullanımı ve hemşirelerin sorumlulukları. Marmara Sağlık Hizmetleri Dergisi. 2017; 1(2): 45-50. doi:10.26567/marsag.2017237426.
Pages
149-158
Published
January 22, 2025
Copyright (c) 2025 Academician Publishing Book Portal
